M C García-Cardona1, F Huang2, J M García-Vivas3, C López-Camarillo4, B E Del Río Navarro5, E Navarro Olivos6, E Hong-Chong7, F Bolaños-Jiménez8, L A Marchat9. 1. Programa de Biomedicina Molecular, Escuela Nacional de Medicina y Homeopatía, Instituto Politécnico Nacional, México City, Mexico. 2. Laboratorio de Farmacología y Toxicología, Hospital Infantil de México Federico Gómez, México City, Mexico. 3. Programa de Biotecnología, Escuela Nacional de Medicina y Homeopatía, Instituto Politécnico Nacional, México City, Mexico. 4. Posgrado en Ciencias Genómicas, Universidad Autónoma de la Ciudad de México, México City, Mexico. 5. Departamento de Alergia, Hospital Infantil de México Federico Gómez, México City, Mexico. 6. Departamento de Salud Pública, Instituto Nacional de Salud Pública, Cuernavaca Morelos, México City, Mexico. 7. Departamento de Farmacología, CINVESTAV-IPN, México City, Mexico. 8. INRA, UMR1280 Physiologie des Adaptations Nutritionnelles, Université de Nantes, Nantes Atlantique Université, Nantes, France. 9. 1] Programa de Biomedicina Molecular, Escuela Nacional de Medicina y Homeopatía, Instituto Politécnico Nacional, México City, Mexico [2] Programa de Biotecnología, Escuela Nacional de Medicina y Homeopatía, Instituto Politécnico Nacional, México City, Mexico.
Abstract
OBJECTIVE: Epigenetic alterations have been suggested to be associated with obesity and related metabolic disorders. Here we examined the correlation between obesity and insulin resistance with the methylation frequency of the leptin (LEP) and adiponectin (ADIPOQ) promoters in obese adolescents with the aim to identify epigenetic markers that might be used as tools to predict and follow up the physiological alterations associated with the development of the metabolic syndrome. SUBJECTS: One hundred and six adolescents were recruited and classified according to body mass index and homeostasis model of assessment-insulin resistance index. The circulating concentrations of leptin, adiponectin and of several metabolic markers of obesity and insulin resistance were determined by standard methods. The methylation frequency of the LEP and ADIPOQ promoters was determined by methylation-specific PCR (MS-PCR) in DNA obtained from peripheral blood samples. RESULTS: Obese adolescents without insulin resistance showed higher and lower circulating levels of, respectively, leptin and adiponectin along with increased plasmatic concentrations of insulin and triglycerides. They also exhibited the same methylation frequency than lean subjects of the CpG sites located at -51 and -31 nt relative to the transcription start site of the LEP gene. However, the methylation frequency of these nucleotides dropped markedly in obese adolescents with insulin resistance. We found the same inverse relationship between the combined presence of obesity and insulin resistance and the methylation frequency of the CpG site located at -283 nt relative to the start site of the ADIPOQ promoter. CONCLUSIONS: These observations sustain the hypothesis that epigenetic modifications might underpin the development of obesity and related metabolic disorders. They also validate the use of blood leukocytes and MS-PCR as a reliable and affordable methodology for the identification of epigenetic modifications that could be used as molecular markers to predict and follow up the physiological changes associated with obesity and insulin resistance.
OBJECTIVE: Epigenetic alterations have been suggested to be associated with obesity and related metabolic disorders. Here we examined the correlation between obesity and insulin resistance with the methylation frequency of the leptin (LEP) and adiponectin (ADIPOQ) promoters in obese adolescents with the aim to identify epigenetic markers that might be used as tools to predict and follow up the physiological alterations associated with the development of the metabolic syndrome. SUBJECTS: One hundred and six adolescents were recruited and classified according to body mass index and homeostasis model of assessment-insulin resistance index. The circulating concentrations of leptin, adiponectin and of several metabolic markers of obesity and insulin resistance were determined by standard methods. The methylation frequency of the LEP and ADIPOQ promoters was determined by methylation-specific PCR (MS-PCR) in DNA obtained from peripheral blood samples. RESULTS:Obese adolescents without insulin resistance showed higher and lower circulating levels of, respectively, leptin and adiponectin along with increased plasmatic concentrations of insulin and triglycerides. They also exhibited the same methylation frequency than lean subjects of the CpG sites located at -51 and -31 nt relative to the transcription start site of the LEP gene. However, the methylation frequency of these nucleotides dropped markedly in obese adolescents with insulin resistance. We found the same inverse relationship between the combined presence of obesity and insulin resistance and the methylation frequency of the CpG site located at -283 nt relative to the start site of the ADIPOQ promoter. CONCLUSIONS: These observations sustain the hypothesis that epigenetic modifications might underpin the development of obesity and related metabolic disorders. They also validate the use of blood leukocytes and MS-PCR as a reliable and affordable methodology for the identification of epigenetic modifications that could be used as molecular markers to predict and follow up the physiological changes associated with obesity and insulin resistance.
Authors: M W Schwartz; R L Prigeon; S E Kahn; M Nicolson; J Moore; A Morawiecki; E J Boyko; D Porte Journal: Diabetes Care Date: 1997-09 Impact factor: 19.112
Authors: Luigi Bouchard; Rémi Rabasa-Lhoret; May Faraj; Marie-Eve Lavoie; Jonathan Mill; Louis Pérusse; Marie-Claude Vohl Journal: Am J Clin Nutr Date: 2009-11-25 Impact factor: 7.045
Authors: B García Cuartero; C García Lacalle; C Jiménez Lobo; A González Vergaz; C Calvo Rey; M J Alcázar Villar; E Díaz Martínez Journal: An Pediatr (Barc) Date: 2007-05 Impact factor: 1.500
Authors: Ana B Crujeiras; Javier Campion; Angel Díaz-Lagares; Fermin I Milagro; Estíbaliz Goyenechea; Itziar Abete; Felipe F Casanueva; J Alfredo Martínez Journal: Regul Pept Date: 2013-07-05
Authors: S Aslibekyan; A N Do; H Xu; S Li; M R Irvin; D Zhi; H K Tiwari; D M Absher; A R Shuldiner; T Zhang; W Chen; K Tanner; C Hong; B D Mitchell; G Berenson; D K Arnett Journal: Nutr Metab Cardiovasc Dis Date: 2016-11-23 Impact factor: 4.222
Authors: C Allard; V Desgagné; J Patenaude; M Lacroix; L Guillemette; M C Battista; M Doyon; J Ménard; J L Ardilouze; P Perron; L Bouchard; M F Hivert Journal: Epigenetics Date: 2015 Impact factor: 4.528